HEADER MEMBRANE PROTEIN 18-JUN-20 6ZFZ TITLE STRUCTURE OF M1-STAR-T4L IN COMPLEX WITH 77-LH-28-1 AT 2.17A COMPND MOL_ID: 1; COMPND 2 MOLECULE: MUSCARINIC ACETYLCHOLINE RECEPTOR M1,ENDOLYSIN,MUSCARINIC COMPND 3 ACETYLCHOLINE RECEPTOR M1; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: LYSIS PROTEIN,LYSOZYME,MURAMIDASE; COMPND 6 EC: 3.2.1.17; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, ENTEROBACTERIA PHAGE T4; SOURCE 3 ORGANISM_COMMON: HUMAN, BACTERIOPHAGE T4; SOURCE 4 ORGANISM_TAXID: 9606, 10665; SOURCE 5 GENE: CHRM1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS GPCR, 7TM, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR P.RUCKTOOA,R.M.COOKE REVDAT 4 24-JAN-24 6ZFZ 1 REMARK REVDAT 3 08-DEC-21 6ZFZ 1 JRNL REVDAT 2 01-DEC-21 6ZFZ 1 JRNL REMARK REVDAT 1 06-OCT-21 6ZFZ 0 JRNL AUTH A.J.H.BROWN,S.J.BRADLEY,F.H.MARSHALL,G.A.BROWN,K.A.BENNETT, JRNL AUTH 2 J.BROWN,J.E.CANSFIELD,D.M.CROSS,C.DE GRAAF,B.D.HUDSON, JRNL AUTH 3 L.DWOMOH,J.M.DIAS,J.C.ERREY,E.HURRELL,J.LIPTROT,G.MATTEDI, JRNL AUTH 4 C.MOLLOY,P.J.NATHAN,K.OKRASA,G.OSBORNE,J.C.PATEL, JRNL AUTH 5 M.PICKWORTH,N.ROBERTSON,S.SHAHABI,C.BUNDGAARD,K.PHILLIPS, JRNL AUTH 6 L.M.BROAD,A.V.GOONAWARDENA,S.R.MORAIRTY,M.BROWNING,F.PERINI, JRNL AUTH 7 G.R.DAWSON,J.F.W.DEAKIN,R.T.SMITH,P.M.SEXTON,J.WARNECK, JRNL AUTH 8 M.VINSON,T.TASKER,B.G.TEHAN,B.TEOBALD,A.CHRISTOPOULOS, JRNL AUTH 9 C.J.LANGMEAD,A.JAZAYERI,R.M.COOKE,P.RUCKTOOA,M.S.CONGREVE, JRNL AUTH10 M.WEIR,A.B.TOBIN JRNL TITL FROM STRUCTURE TO CLINIC: DESIGN OF A MUSCARINIC M1 RECEPTOR JRNL TITL 2 AGONIST WITH POTENTIAL TO TREATMENT OF ALZHEIMER'S DISEASE. JRNL REF CELL V. 184 5886 2021 JRNL REFN ISSN 1097-4172 JRNL PMID 34822784 JRNL DOI 10.1016/J.CELL.2021.11.001 REMARK 2 REMARK 2 RESOLUTION. 2.17 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 72.3 REMARK 3 NUMBER OF REFLECTIONS : 25204 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.740 REMARK 3 FREE R VALUE TEST SET COUNT : 1194 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.17 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.31 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 8.72 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 505 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2346 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 493 REMARK 3 BIN R VALUE (WORKING SET) : 0.2318 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 2.38 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 12 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3556 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 249 REMARK 3 SOLVENT ATOMS : 33 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.85270 REMARK 3 B22 (A**2) : 5.50730 REMARK 3 B33 (A**2) : -1.65460 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.350 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.317 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.224 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.324 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.228 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.919 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.903 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3896 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5232 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1436 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 614 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3896 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 491 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4330 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.90 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.22 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.80 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|20 - A|219 A|354 - A|439 } REMARK 3 ORIGIN FOR THE GROUP (A): 20.8746 17.9193 6.0000 REMARK 3 T TENSOR REMARK 3 T11: -0.1087 T22: -0.0055 REMARK 3 T33: -0.1069 T12: -0.0095 REMARK 3 T13: -0.0283 T23: -0.0058 REMARK 3 L TENSOR REMARK 3 L11: 1.7828 L22: 0.6279 REMARK 3 L33: 2.1592 L12: -0.0483 REMARK 3 L13: -0.2085 L23: -0.1600 REMARK 3 S TENSOR REMARK 3 S11: -0.0063 S12: -0.2301 S13: -0.0384 REMARK 3 S21: 0.0708 S22: -0.0072 S23: 0.0113 REMARK 3 S31: -0.0064 S32: -0.0201 S33: 0.0135 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { A|1002 - A|1161 } REMARK 3 ORIGIN FOR THE GROUP (A): 13.2308 -3.0518 41.8884 REMARK 3 T TENSOR REMARK 3 T11: -0.1504 T22: -0.1255 REMARK 3 T33: -0.3040 T12: 0.0777 REMARK 3 T13: 0.0434 T23: 0.1079 REMARK 3 L TENSOR REMARK 3 L11: 5.6083 L22: 3.5569 REMARK 3 L33: 3.3624 L12: 1.3782 REMARK 3 L13: -0.8420 L23: -1.3789 REMARK 3 S TENSOR REMARK 3 S11: -0.1832 S12: 0.2866 S13: -0.1318 REMARK 3 S21: -0.0311 S22: -0.1173 S23: -0.2697 REMARK 3 S31: 0.2305 S32: 0.1743 S33: 0.3004 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ZFZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1292109482. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.4-7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I24 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.96861 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25204 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.170 REMARK 200 RESOLUTION RANGE LOW (A) : 50.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.1 REMARK 200 DATA REDUNDANCY : 5.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.17 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2Y00 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.09 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M NAHEPES PH 7.4-7.8, 0.1M DI REMARK 280 -AMMONIUM HYDROGENPHOSPHATE, 30-38% PEG300, LIPIDIC CUBIC PHASE, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.17050 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.29800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.81550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.29800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.17050 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 32.81550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4830 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24300 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 440 REMARK 465 HIS A 441 REMARK 465 HIS A 442 REMARK 465 HIS A 443 REMARK 465 HIS A 444 REMARK 465 HIS A 445 REMARK 465 HIS A 446 REMARK 465 HIS A 447 REMARK 465 HIS A 448 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 77 -69.86 -94.78 REMARK 500 LEU A 131 -60.33 -100.53 REMARK 500 SER A 184 -75.60 -69.54 REMARK 500 PHE A 197 -64.27 -131.18 REMARK 500 PHE A1114 53.45 -90.55 REMARK 500 LYS A 392 -70.18 -30.66 REMARK 500 REMARK 500 REMARK: NULL DBREF 6ZFZ A 27 219 UNP P11229 ACM1_HUMAN 27 219 DBREF 6ZFZ A 1002 1161 UNP P00720 ENLYS_BPT4 2 161 DBREF 6ZFZ A 354 438 UNP P11229 ACM1_HUMAN 354 438 SEQADV 6ZFZ MET A 20 UNP P11229 INITIATING METHIONINE SEQADV 6ZFZ GLU A 21 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ THR A 22 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ VAL A 23 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ GLU A 24 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ MET A 25 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ VAL A 26 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ ALA A 27 UNP P11229 PHE 27 ENGINEERED MUTATION SEQADV 6ZFZ ALA A 29 UNP P11229 GLY 29 CONFLICT SEQADV 6ZFZ THR A 30 UNP P11229 ILE 30 CONFLICT SEQADV 6ZFZ VAL A 31 UNP P11229 THR 31 CONFLICT SEQADV 6ZFZ ALA A 32 UNP P11229 THR 32 ENGINEERED MUTATION SEQADV 6ZFZ ILE A 44 UNP P11229 LEU 44 ENGINEERED MUTATION SEQADV 6ZFZ LEU A 46 UNP P11229 VAL 46 ENGINEERED MUTATION SEQADV 6ZFZ MET A 47 UNP P11229 LEU 47 CONFLICT SEQADV 6ZFZ LEU A 48 UNP P11229 ILE 48 CONFLICT SEQADV 6ZFZ ILE A 50 UNP P11229 PHE 50 CONFLICT SEQADV 6ZFZ ARG A 54 UNP P11229 THR 54 CONFLICT SEQADV 6ZFZ GLN A 55 UNP P11229 GLU 55 CONFLICT SEQADV 6ZFZ GLN A 57 UNP P11229 LYS 57 CONFLICT SEQADV 6ZFZ ALA A 64 UNP P11229 LEU 64 ENGINEERED MUTATION SEQADV 6ZFZ PHE A 65 UNP P11229 LEU 65 CONFLICT SEQADV 6ZFZ ALA A 76 UNP P11229 THR 76 ENGINEERED MUTATION SEQADV 6ZFZ VAL A 84 UNP P11229 THR 84 ENGINEERED MUTATION SEQADV 6ZFZ ILE A 86 UNP P11229 LEU 86 CONFLICT SEQADV 6ZFZ ILE A 87 UNP P11229 LEU 87 CONFLICT SEQADV 6ZFZ ALA A 95 UNP P11229 THR 95 ENGINEERED MUTATION SEQADV 6ZFZ ALA A 101 UNP P11229 TRP 101 ENGINEERED MUTATION SEQADV 6ZFZ ALA A 112 UNP P11229 SER 112 ENGINEERED MUTATION SEQADV 6ZFZ LEU A 143 UNP P11229 ALA 143 ENGINEERED MUTATION SEQADV 6ZFZ THR A 196 UNP P11229 ALA 196 ENGINEERED MUTATION SEQADV 6ZFZ GLY A 1012 UNP P00720 ARG 12 CONFLICT SEQADV 6ZFZ THR A 1054 UNP P00720 CYS 54 CONFLICT SEQADV 6ZFZ ALA A 1097 UNP P00720 CYS 97 CONFLICT SEQADV 6ZFZ ARG A 1137 UNP P00720 ILE 137 CONFLICT SEQADV 6ZFZ ALA A 362 UNP P11229 LYS 362 ENGINEERED MUTATION SEQADV 6ZFZ LEU A 364 UNP P11229 ALA 364 ENGINEERED MUTATION SEQADV 6ZFZ ALA A 411 UNP P11229 SER 411 ENGINEERED MUTATION SEQADV 6ZFZ ALA A 435 UNP P11229 CYS 435 CONFLICT SEQADV 6ZFZ HIS A 439 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 440 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 441 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 442 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 443 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 444 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 445 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 446 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 447 UNP P11229 EXPRESSION TAG SEQADV 6ZFZ HIS A 448 UNP P11229 EXPRESSION TAG SEQRES 1 A 455 MET GLU THR VAL GLU MET VAL ALA ILE ALA THR VAL ALA SEQRES 2 A 455 GLY LEU LEU SER LEU ALA THR VAL THR GLY ASN ILE LEU SEQRES 3 A 455 LEU MET LEU SER ILE LYS VAL ASN ARG GLN LEU GLN THR SEQRES 4 A 455 VAL ASN ASN TYR PHE ALA PHE SER LEU ALA CYS ALA ASP SEQRES 5 A 455 LEU ILE ILE GLY ALA PHE SER MET ASN LEU TYR THR VAL SEQRES 6 A 455 TYR ILE ILE MET GLY HIS TRP ALA LEU GLY ALA LEU ALA SEQRES 7 A 455 CYS ASP LEU ALA LEU ALA LEU ASP TYR VAL ALA SER ASN SEQRES 8 A 455 ALA ALA VAL MET ASN LEU LEU LEU ILE SER PHE ASP ARG SEQRES 9 A 455 TYR PHE SER VAL THR ARG PRO LEU SER TYR ARG ALA LYS SEQRES 10 A 455 ARG THR PRO ARG ARG ALA LEU LEU MET ILE GLY LEU ALA SEQRES 11 A 455 TRP LEU VAL SER PHE VAL LEU TRP ALA PRO ALA ILE LEU SEQRES 12 A 455 PHE TRP GLN TYR LEU VAL GLY GLU ARG THR VAL LEU ALA SEQRES 13 A 455 GLY GLN CYS TYR ILE GLN PHE LEU SER GLN PRO ILE ILE SEQRES 14 A 455 THR PHE GLY THR ALA MET ALA THR PHE TYR LEU PRO VAL SEQRES 15 A 455 THR VAL MET CYS THR LEU TYR TRP ARG ILE TYR ARG GLU SEQRES 16 A 455 THR GLU ASN ARG ALA ASN ILE PHE GLU MET LEU ARG ILE SEQRES 17 A 455 ASP GLU GLY LEU ARG LEU LYS ILE TYR LYS ASP THR GLU SEQRES 18 A 455 GLY TYR TYR THR ILE GLY ILE GLY HIS LEU LEU THR LYS SEQRES 19 A 455 SER PRO SER LEU ASN ALA ALA LYS SER GLU LEU ASP LYS SEQRES 20 A 455 ALA ILE GLY ARG ASN THR ASN GLY VAL ILE THR LYS ASP SEQRES 21 A 455 GLU ALA GLU LYS LEU PHE ASN GLN ASP VAL ASP ALA ALA SEQRES 22 A 455 VAL ARG GLY ILE LEU ARG ASN ALA LYS LEU LYS PRO VAL SEQRES 23 A 455 TYR ASP SER LEU ASP ALA VAL ARG ARG ALA ALA LEU ILE SEQRES 24 A 455 ASN MET VAL PHE GLN MET GLY GLU THR GLY VAL ALA GLY SEQRES 25 A 455 PHE THR ASN SER LEU ARG MET LEU GLN GLN LYS ARG TRP SEQRES 26 A 455 ASP GLU ALA ALA VAL ASN LEU ALA LYS SER ARG TRP TYR SEQRES 27 A 455 ASN GLN THR PRO ASN ARG ALA LYS ARG VAL ILE THR THR SEQRES 28 A 455 PHE ARG THR GLY THR TRP ASP ALA TYR THR PHE SER LEU SEQRES 29 A 455 VAL LYS GLU LYS ALA ALA LEU ARG THR LEU SER ALA ILE SEQRES 30 A 455 LEU LEU ALA PHE ILE LEU THR TRP THR PRO TYR ASN ILE SEQRES 31 A 455 MET VAL LEU VAL SER THR PHE CYS LYS ASP CYS VAL PRO SEQRES 32 A 455 GLU THR LEU TRP GLU LEU GLY TYR TRP LEU CYS TYR VAL SEQRES 33 A 455 ASN ALA THR ILE ASN PRO MET CYS TYR ALA LEU CYS ASN SEQRES 34 A 455 LYS ALA PHE ARG ASP THR PHE ARG LEU LEU LEU LEU ALA SEQRES 35 A 455 ARG TRP ASP HIS HIS HIS HIS HIS HIS HIS HIS HIS HIS HET QJT A1201 24 HET OLA A1202 20 HET OLA A1203 20 HET OLA A1204 20 HET OLA A1205 20 HET PO4 A1206 5 HET OLA A1207 20 HET OLA A1208 20 HET OLA A1209 20 HET OLA A1210 20 HET OLC A1211 25 HET EPE A1212 15 HET PGE A1213 10 HET PGE A1214 10 HETNAM QJT 1-[3-(4-BUTYLPIPERIDIN-1-YL)PROPYL]-3,4- HETNAM 2 QJT DIHYDROQUINOLIN-2-ONE HETNAM OLA OLEIC ACID HETNAM PO4 PHOSPHATE ION HETNAM OLC (2R)-2,3-DIHYDROXYPROPYL (9Z)-OCTADEC-9-ENOATE HETNAM EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID HETNAM PGE TRIETHYLENE GLYCOL HETSYN OLC 1-OLEOYL-R-GLYCEROL HETSYN EPE HEPES FORMUL 2 QJT C21 H32 N2 O FORMUL 3 OLA 8(C18 H34 O2) FORMUL 7 PO4 O4 P 3- FORMUL 12 OLC C21 H40 O4 FORMUL 13 EPE C8 H18 N2 O4 S FORMUL 14 PGE 2(C6 H14 O4) FORMUL 16 HOH *33(H2 O) HELIX 1 AA1 GLU A 21 ASN A 53 1 33 HELIX 2 AA2 ARG A 54 GLN A 57 5 4 HELIX 3 AA3 THR A 58 PHE A 77 1 20 HELIX 4 AA4 PHE A 77 GLY A 89 1 13 HELIX 5 AA5 GLY A 94 ARG A 129 1 36 HELIX 6 AA6 SER A 132 LYS A 136 5 5 HELIX 7 AA7 THR A 138 GLY A 169 1 32 HELIX 8 AA8 GLN A 185 PHE A 197 1 13 HELIX 9 AA9 PHE A 197 GLU A 1011 1 33 HELIX 10 AB1 SER A 1038 GLY A 1051 1 14 HELIX 11 AB2 THR A 1059 ASN A 1081 1 23 HELIX 12 AB3 LEU A 1084 LEU A 1091 1 8 HELIX 13 AB4 ASP A 1092 GLY A 1113 1 22 HELIX 14 AB5 PHE A 1114 GLN A 1123 1 10 HELIX 15 AB6 ARG A 1125 LYS A 1135 1 11 HELIX 16 AB7 SER A 1136 THR A 1142 1 7 HELIX 17 AB8 THR A 1142 GLY A 1156 1 15 HELIX 18 AB9 LYS A 361 CYS A 391 1 31 HELIX 19 AC1 PRO A 396 VAL A 409 1 14 HELIX 20 AC2 VAL A 409 ASN A 422 1 14 HELIX 21 AC3 ASN A 422 ASP A 438 1 17 SHEET 1 AA1 3 ARG A1014 LYS A1019 0 SHEET 2 AA1 3 TYR A1025 GLY A1028 -1 O THR A1026 N TYR A1018 SHEET 3 AA1 3 HIS A1031 THR A1034 -1 O LEU A1033 N TYR A1025 SSBOND 1 CYS A 98 CYS A 178 1555 1555 2.05 SSBOND 2 CYS A 391 CYS A 394 1555 1555 2.04 CISPEP 1 ASP A 438 HIS A 439 0 2.13 CRYST1 62.341 65.631 156.596 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016041 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015237 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006386 0.00000